Literature DB >> 23224455

Motor and non-motor symptoms in Turkish patients with Parkinson's disease affecting family caregiver burden and quality of life.

Betul Ozdilek1, Dilek Ince Gunal.   

Abstract

Parkinson's disease (PD) decreases the quality of life (QoL) of both caregivers and patients by increasing stress and burden, and it has a negative impact on their psychological state. In the present study, the authors examined the impact of PD-patient motor and non-motor clinical symptoms on the psychological health, burden, and QoL of Turkish caregivers. The study included 50 patients with PD and their caregivers. Patients' disease severity and disability, motor and non-motor symptoms, disease complications, sleep disturbances, anxiety, and depressive symptoms were assessed with various scales. Data were analyzed by multiple linear-regression models to identify variables associated with caregiver burden, psychological status, and QoL. Anxiety and depressive symptoms exhibited by the patients significantly affected the psychological state of the caregivers. Caregiver burden was increased by disease severity; the patient's degree of disability, anxiety, and depressive symptoms; and excessive daytime sleepiness. Caregiver QoL was significantly affected by the presence of dyskinesia, sialorrhea, and anxiety symptoms in patients with PD. These findings indicate that caregiving for patients with PD, particularly those in later stages, with psychiatric symptoms, affects caregiver psychological status, QoL, and caregiver burden. These results can be used to develop treatment approaches to improve caregivers' psychological status and QoL and decrease caregiver burden.

Entities:  

Mesh:

Year:  2012        PMID: 23224455     DOI: 10.1176/appi.neuropsych.11100315

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  19 in total

1.  Assessment of Duodopa® effects on quality of life of patients with advanced Parkinson's disease and their caregivers.

Authors:  Rosella Ciurleo; Francesco Corallo; Lilla Bonanno; Viviana Lo Buono; Giuseppe Di Lorenzo; Roberta Versaci; Cettina Allone; Rosanna Palmeri; Placido Bramanti; Silvia Marino
Journal:  J Neurol       Date:  2018-06-27       Impact factor: 4.849

Review 2.  Drooling in Parkinson's disease: a review.

Authors:  Prachaya Srivanitchapoom; Sanjay Pandey; Mark Hallett
Journal:  Parkinsonism Relat Disord       Date:  2014-08-27       Impact factor: 4.891

Review 3.  Disturbances of Sleep and Alertness in Parkinson's Disease.

Authors:  Aleksandar Videnovic
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-19       Impact factor: 5.081

Review 4.  A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015.

Authors:  Lama M Chahine; Amy W Amara; Aleksandar Videnovic
Journal:  Sleep Med Rev       Date:  2016-08-31       Impact factor: 11.609

Review 5.  Treatment of Sleep Dysfunction in Parkinson's Disease.

Authors:  Amy W Amara; Lana M Chahine; Aleksandar Videnovic
Journal:  Curr Treat Options Neurol       Date:  2017-07       Impact factor: 3.598

Review 6.  Evaluation of quality of life in individuals with severe chronic motor disability: A major challenge.

Authors:  Marie-Christine Rousseau; Karine Baumstarck; Thierry Billette de Villemeur; Pascal Auquier
Journal:  Intractable Rare Dis Res       Date:  2016-05

7.  Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial.

Authors:  Fabian Büchele; Marc Hackius; Sebastian R Schreglmann; Wolfgang Omlor; Esther Werth; Angelina Maric; Lukas L Imbach; Stefan Hägele-Link; Daniel Waldvogel; Christian R Baumann
Journal:  JAMA Neurol       Date:  2018-01-01       Impact factor: 18.302

8.  Social phobia in Parkinson's disease: Prevalence and risk factors.

Authors:  Bulent Kadri Gultekin; Betul Ozdilek; Engin Emrem Bestepe
Journal:  Neuropsychiatr Dis Treat       Date:  2014-05-21       Impact factor: 2.570

9.  Neuropsychiatric symptoms in Parkinson's disease dementia are associated with increased caregiver burden.

Authors:  Yoon-Sang Oh; Ji E Lee; Phil Hyu Lee; Joong-Seok Kim
Journal:  J Mov Disord       Date:  2015-01-13

10.  Motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational study.

Authors:  Leonardo Lopiano; Nicola Modugno; Pietro Marano; Mariachiara Sensi; Giuseppe Meco; Antonino Cannas; Graziano Gusmaroli; Filippo Tamma; Francesca Mancini; Rocco Quatrale; Anna Maria Costanzo; Giuliana Gualberti; Gabriella Melzi; Umberto di Luzio Paparatti; Angelo Antonini
Journal:  Neurol Sci       Date:  2016-07-15       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.